Spero Therapeutics (SPRO) Short Interest Ratio & Short Volume → Biden out June 13; Kamala won’t replace him? (From Paradigm Press) (Ad) Free SPRO Stock Alerts $1.44 -0.02 (-1.37%) (As of 04/29/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Spero Therapeutics Short Interest DataCurrent Short Volume513,200 sharesPrevious Short Volume653,800 sharesChange Vs. Previous Month-21.51%Dollar Volume Sold Short$785,196.00Short Interest Ratio / Days to Cover1.6Last Record DateApril 15, 2024Outstanding Shares53,890,000 sharesPercentage of Shares Shorted0.95%Today's Trading Volume170,558 sharesAverage Trading Volume227,481 sharesToday's Volume Vs. Average75% Short Selling Spero Therapeutics ? Sign up to receive the latest short interest report for Spero Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSPRO Short Interest Over TimeSPRO Days to Cover Over TimeSPRO Percentage of Float Shorted Over Time Ad DTIthe harsh reality of the stock marketOK, you’re not supposed to say this In fact, maverick investor Graham Lindman says it’s become the silent elephant in the room that everyone is pretending isn’t there. But he just said it: Most stocks suck. And he isn’t saying that figuratively or subjectively… You see, 96% of stocks underperform. Just 4% of “Apex Stocks” generate virtually all the wealth.All you have to do is watch here for all the details. Spero Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024513,200 shares $785,196.00 -21.5%N/A1.6 $1.53 3/31/2024653,800 shares $1.12 million +6.5%N/A2.1 $1.72 3/15/2024613,900 shares $1.10 million +8.9%N/A2 $1.79 2/29/2024564,000 shares $930,600.00 -8.9%N/A2.8 $1.65 2/15/2024619,000 shares $940,880.00 -12.5%N/A3.2 $1.52 1/31/2024707,100 shares $1.07 million +4.0%N/A3.8 $1.52 Get the Latest News and Ratings for SPRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Spero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024680,200 shares $986,290.00 -13.8%N/A4 $1.45 12/31/2023789,000 shares $1.16 million -19.2%N/A4.5 $1.47 12/15/2023976,500 shares $1.26 million -9.6%N/A6 $1.29 11/30/20231,080,000 shares $1.23 million -4.4%N/A6.2 $1.14 11/15/20231,130,000 shares $1.29 million -10.3%N/A4.7 $1.14 10/31/20231,260,000 shares $1.36 million -3.1%N/A4.8 $1.08 10/15/20231,300,000 shares $1.47 million -3.7%N/A4.1 $1.13 9/30/20231,350,000 shares $1.63 million -5.6%N/A4.2 $1.21 9/15/20231,430,000 shares $1.83 million +25.4%N/A4.3 $1.28 8/31/20231,140,000 shares $1.71 million No ChangeN/A3.2 $1.50 8/15/20231,140,000 shares $1.53 million -2.6%N/A3.8 $1.35 7/31/20231,170,000 shares $1.91 million No ChangeN/A3.9 $1.63 7/15/20231,170,000 shares $1.77 million -4.9%N/A4.2 $1.51 6/30/20231,230,000 shares $1.78 million +40.4%N/A4 $1.45 6/15/2023876,300 shares $1.38 million -0.6%N/A1.8 $1.57 5/31/2023881,800 shares $1.53 million -9.5%N/A1.7 $1.74 5/15/2023974,400 shares $1.82 million -32.8%N/A1.7 $1.87 4/30/20231,450,000 shares $2.57 million -21.6%N/A2.5 $1.77 4/15/20231,850,000 shares $3.18 million +17.1%N/A3.3 $1.72 3/31/20231,580,000 shares $2.29 million +67.6%N/A2.8 $1.45 3/15/2023942,700 shares $1.39 million +142.0%N/A2.1 $1.47 2/28/2023389,500 shares $576,460.00 +35.5%N/A0.9 $1.48 2/15/2023287,400 shares $514,446.00 -38.6%N/A0.7 $1.79 1/31/2023468,200 shares $866,170.00 -29.9%N/A0.8 $1.85 1/15/2023667,900 shares $1.34 million -21.4%N/A1.1 $2.00 12/30/2022849,400 shares $1.47 million -14.6%N/A1.1 $1.73 12/15/2022994,200 shares $1.69 million -23.5%N/A0.4 $1.70 11/30/20221,300,000 shares $2.52 million -13.9%N/A0.2 $1.94 11/15/20221,510,000 shares $2.84 million +22.8%5.5%0.2 $1.88 10/31/20221,230,000 shares $2.41 million -15.8%4.5%0.2 $1.96 10/15/20221,460,000 shares $2.89 million -32.4%5.4%0.2 $1.98 9/30/20222,160,000 shares $4.32 million +177.9%8.0%0.3 $2.00 9/15/2022777,200 shares $753,884.00 +182.0%2.9%0.1 $0.97 8/31/2022275,600 shares $222,381.64 -32.9%1.0%0.1 $0.81the harsh reality of the stock market (Ad)OK, you’re not supposed to say this In fact, maverick investor Graham Lindman says it’s become the silent elephant in the room that everyone is pretending isn’t there. But he just said it: Most stocks suck. And he isn’t saying that figuratively or subjectively… You see, 96% of stocks underperform. Just 4% of “Apex Stocks” generate virtually all the wealth.All you have to do is watch here for all the details. SPRO Short Interest - Frequently Asked Questions What is Spero Therapeutics' current short interest? Short interest is the volume of Spero Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 513,200 shares of SPRO short. Learn More on Spero Therapeutics' current short interest. What is a good short interest ratio for Spero Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SPRO shares currently have a short interest ratio of 2.0. Learn More on Spero Therapeutics's short interest ratio. Is Spero Therapeutics' short interest increasing or decreasing? Spero Therapeutics saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 513,200 shares, a decline of 21.5% from the previous total of 653,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Spero Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Spero Therapeutics: Connect Biopharma Holdings Limited (0.16%), Tempest Therapeutics, Inc. (6.74%), Hookipa Pharma Inc (0.45%), Marinus Pharmaceuticals, Inc. (8.23%), YS Biopharma Co., Ltd. (0.53%), Corvus Pharmaceuticals, Inc. (3.71%), Oncolytics Biotech Inc. (1.23%), InflaRx (0.22%), Aileron Therapeutics, Inc. (0.31%), vTv Therapeutics Inc. (3.44%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Spero Therapeutics stock? Short selling SPRO is an investing strategy that aims to generate trading profit from Spero Therapeutics as its price is falling. SPRO shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Spero Therapeutics? A short squeeze for Spero Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SPRO, which in turn drives the price of the stock up even further. How often is Spero Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPRO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Connect Biopharma Short Interest Tempest Therapeutics Short Interest Hookipa Pharma Short Interest Marinus Pharmaceuticals Short Interest YS Biopharma Short Interest Corvus Pharmaceuticals Short Interest Oncolytics Biotech Short Interest InflaRx Short Interest Aileron Therapeutics Short Interest vTv Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SPRO) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsWhy Big Pharma is Investing Billions in This BiotechBehind the Markets